Piper Sandler & Co’s bluebird bio BLUE Stock Holding History

Piper Sandler & Co’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-174	Closed	-$145K	–	19
2015 Q4	$145K	Buy	+174	New	+$174K	0.37%	15

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Piper Sandler & Co's BLUE Position: Q1 2016 in Review

Piper Sandler & Co sold out of bluebird bio (BLUE) in Q1 2016, closing a stake of 174 shares — an estimated $145K sold.

Piper Sandler & Co first reported a position in BLUE in Q4 2015 and held it in 1 quarter. The position peaked at $145K in Q4 2015. 187 funds tracked by Wall St. Rank hold BLUE as of Q1 2016.

Piper Sandler & Co reported no remaining bluebird bio position as of Q1 2016 after selling out during the quarter.
Piper Sandler & Co sold 174 bluebird bio shares in Q1 2016, an estimated $145K.
Piper Sandler & Co first reported a position in bluebird bio in Q4 2015 and held it in 1 quarter.
Piper Sandler & Co's bluebird bio position peaked at $145K in Q4 2015.
187 funds tracked by Wall St. Rank held bluebird bio as of Q1 2016.

Based on Piper Sandler & Co's 13F filing for Q1 2016, filed 16 May 2016.